‘A Tipping Point’, Says Prime Minister Modi, As Oxford, Bharat Biotech’s Covid-19 Vaccines Gain Restricted Emergency Use Approval | India News

NEW DELHI: Prime Minister Narendra Modi congratulated the nation on Sunday and thanked the scientific and health community after the Controller General of Drugs of India (DCGI) gave final approval to the Oxford-AstraZeneca and Covaxin Covishield vaccines from Bharat Biotech for emergency use.
The announcement marks a “decisive turning point” in India’s energetic fight against the Covid-19 pandemic, Prime Minister Modi said shortly after the announcement. Prime Minister Modi said this will speed up the process for India to become a Covid-free nation. “All of India would be proud that both vaccines are” made in India, “Prime Minister Modi said on Twitter.
DCGI today approved the Oxford Covid-19 Covishield vaccine, manufactured by the Serum Institute, and locally developed Bharat Biotech’s Covaxin for restricted emergency use in the country, paving the way for a massive inoculation campaign. The approval by the DCGI was given on the basis of the recommendations presented by a committee of experts in the field (SEC) of COVID-19 of the Central Organization for the Control of Drug Standards (CDSCO).

In a series of tweets, Prime Minister Modi said that all Indians would be proud that the two vaccines that received approval for emergency use were manufactured in India. This shows the enthusiasm of our scientific community to fulfill the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.

The Prime Minister once again extended his gratitude to the doctors, medical personnel, scientists, police personnel, sanitation workers and all ‘Crown warriors’ for the outstanding work they have done in adverse circumstances, and said that the nation will remain eternally grateful for saving. many lives.

The Serum Institute of India, the world’s largest vaccine manufacturer, has partnered with AstraZeneca to manufacture Covishield.
Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR).